I am passionate about creating tailored sale processes for each of my clients to meet their individual needs, and then executing the process tirelessly to achieve the best price and terms for the selling shareholders.
Emily provides mergers and acquisitions (M&A) advisory to global clients across the healthcare industry, with an emphasis on private equity-backed sell-side transactions. Over her career, Emily has successfully completed more than 90 transactions, representing aggregate transaction value in excess of $15 billion.
Emily has a strong track record of executing transactions in the provider-based services, animal health and healthcare distribution sectors. Within provider-based services, she has worked with leading for-profit companies in the ambulatory surgery center, physical therapy clinic, specialty physician practice, healthcare staffing and behavioral health sub-sectors.
Prior to joining Lincoln, Emily spent 16 years at Piper Sandler & Co., formerly known as Piper Jaffray & Co.
Emily graduated from Indiana University with a bachelor’s degree in finance.
Recent Transactions in Healthcare
Lincoln International is pleased to announce that it served as the exclusive financial advisor to Alva-Amco Pharmacal in its sale to Kobayashi Pharmaceutical Co., Ltd. (TSE:4967)
Lincoln International is pleased to announce that Choice Health Insurance, LLC, a fully integrated consumer acquisition platform specializing in the high-growth, Medicare Advantage marketplace, has been acquired by Alight Solutions, a portfolio company of Blackstone
Lincoln International is pleased to announce that UAS Laboratories LLC, a portfolio company of Lakeview Equity Partners, LLC, has been sold to Chr. Hansen Holding A/S (CPSE:CHR), a leading, global bioscience company that develops natural ingredient solutions for the food, nutritional, pharmaceutical and agricultural industries
Lincoln International is pleased to announce that it has advised Doppel Farmaceutici, a portfolio company of Trilantic Europe, on the financing of its acquisition of Dietopack
Lincoln International is pleased to announce that The Araz Group, Inc. (d/b/a HealthEZ) has received an investment from Abry Partners LP
Lincoln International advised Gruppo Sapio on the acquisition of a majority stake in Homeperf from Parquest Capital; BNP Paribas Développement and Arkea Capital will reinvest in the business alongside Sapio
Lincoln International is pleased to announce that it has advised IntegriChain, Inc. on the acquisition of the life sciences division of Cumberland
Lincoln International is pleased to announce the sale of substantially all of the operating assets of Valeritas Holdings, Inc. (NASDAQ:VLRX) pursuant to Section 363 of the U.S. Bankruptcy Code to Zealand Pharma A/S (NASDAQ:ZEAL)